Elham Mahabadi-Ashtiyani1, Vida Sheikh2, Shiva Borzouei2, Iraj Salehi3, Mahdi Alahgholi-Hajibehzad4. 1. Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. 2. Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. 3. Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. 4. Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. m.hajibehzad@umsha.ac.ir.
Abstract
OBJECTIVE: The probably effects of sitagliptin and vitamin D3 (VitD3) on proliferation capacity and cytokines production were investigated in type 2 diabetes mellitus (T2DM) in vitro. MATERIALS AND METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from 35 patients with T2DM and 26 healthy controls (HCs). CFSE-labeled PBMCs stimulated with phytohamagglutinin (PHA, 5 μg/mL) in the presence/absence of sitagliptin (200 mg/mL) with/without VitD3 (10-8 M) for 4 days. The proliferation of CD4+ T helper cells and non-CD4+ cells was analyzed using flow cytometry. The supernatant levels of IFN-γ, IL-17, IL-4, TGB-β and IL-37 were detected using ELISA. RESULTS: The proliferation of CD4+ T cells in response to PHA was higher in T2DM patients compared with HCs. The production of IFN-γ and IL-17 in PHA-stimulated cultures was higher, and the levels of IL-4 and IL-37 were lower in T2DM patients compared to HCs. The addition of sitagliptin or VitD3 to the cultures decreased the CD4+ T cells and non-CD4+ cells proliferation in patients and HCs. Sitagliptin with VitD3 was more effective in suppression of proliferation, decreasing of IL-17 and enhancing of IL-37 production. CONCLUSION: Sitagliptin plus VitD3 effectively reduces the proliferative T cells response and modulates pro-inflammatory/anti-inflammatory cytokines production.
OBJECTIVE: The probably effects of sitagliptin and vitamin D3 (VitD3) on proliferation capacity and cytokines production were investigated in type 2 diabetes mellitus (T2DM) in vitro. MATERIALS AND METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from 35 patients with T2DM and 26 healthy controls (HCs). CFSE-labeled PBMCs stimulated with phytohamagglutinin (PHA, 5 μg/mL) in the presence/absence of sitagliptin (200 mg/mL) with/without VitD3 (10-8 M) for 4 days. The proliferation of CD4+ T helper cells and non-CD4+ cells was analyzed using flow cytometry. The supernatant levels of IFN-γ, IL-17, IL-4, TGB-β and IL-37 were detected using ELISA. RESULTS: The proliferation of CD4+ T cells in response to PHA was higher in T2DM patients compared with HCs. The production of IFN-γ and IL-17 in PHA-stimulated cultures was higher, and the levels of IL-4 and IL-37 were lower in T2DM patients compared to HCs. The addition of sitagliptin or VitD3 to the cultures decreased the CD4+ T cells and non-CD4+ cells proliferation in patients and HCs. Sitagliptin with VitD3 was more effective in suppression of proliferation, decreasing of IL-17 and enhancing of IL-37 production. CONCLUSION:Sitagliptin plus VitD3 effectively reduces the proliferative T cells response and modulates pro-inflammatory/anti-inflammatory cytokines production.
Entities:
Keywords:
Cytokine; Proliferation; Sitagliptin; T cell; T2DM; Vitamin D3
Authors: Dov B Ballak; Janna A van Diepen; Alexander R Moschen; Henry J Jansen; Anneke Hijmans; Gert-Jan Groenhof; Floris Leenders; Philip Bufler; Mark V Boekschoten; Michael Müller; Sander Kersten; Suzhao Li; SooHyun Kim; Hadar Eini; Eli C Lewis; Leo A B Joosten; Herbert Tilg; Mihai G Netea; Cees J Tack; Charles A Dinarello; Rinke Stienstra Journal: Nat Commun Date: 2014-09-03 Impact factor: 14.919
Authors: M Alahgholi-Hajibehzad; H Durmuş; F Aysal; Y Gülşen-Parman; P Oflazer; F Deymeer; G Saruhan-Direskeneli Journal: Clin Exp Immunol Date: 2017-07-28 Impact factor: 4.330
Authors: Mauricio Castillo-Salazar; Fausto Sánchez-Muñoz; Rashidi Springall Del Villar; Gabriel Navarrete-Vázquez; Adrián Hernández-DiazCouder; Carlos Mojica-Cardoso; Sara García-Jiménez; Cairo Toledano-Jaimes; Germán Bernal-Fernández Journal: Biomolecules Date: 2021-12-02